Schedule 13D ownership disclosure

LUMOS PHARMA INC

Security class unavailable · CUSIP: 55028X109

Event date: 2023-02-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
760,000
Percent of class
9.0700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001062993-23-003537
Form type
SC 13D
Filer
Farb Daniel Stuart
CIK
CIK 1776353
Filed
Feb 15, 2023
Reporting period
Feb 13, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub